Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1H-116PI-DE.pdf----1件: 18
2H-ATG (ATGAM )1件: Antilymphocyte immunoglobulin (horse)---1件: 60
3H.P. Acthar Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 46, 49, 50, 84, 222
4H.P. Acthar Gel (repository corticotropin injection)1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13
5H.P. Acthar® Gel1件: Corticotropin1件: D00146 1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 14
6H01AC01----1件: 78
7H01BB02----1件: 193
8H02 - Corticosteroidi Sistemici----1件: 299
9H02AB----1件: 97
10H02AB02----1件: 28
11H02AB02 Desametasone----1件: 28
12H02AB04----1件: 46
13H02AB07----1件: 46
14H02AB09----1件: 41
15H05AA02----1件: 274
16H1 Blocker----1件: 257
17H2 Blocker----1件: 257
18H44AON188----1件: 113
19H51AON23----1件: 113
20H5G1.1-mAb----3件: 13, 50, 62
21HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM----2件: 6, 49
22HA20 (IMMU-106)----1件: 46
23Habitrol----1件: 84
24Haemate P----1件: 288
25Haemate P® (Human Coagulation Factor VIII)2件: Antihemophilic factor human,
Beroctocog alfa		---1件: 288
26Haemate-P, Wilate1件: Von Willebrand factor human---1件: 288
27Haemate® P 250----1件: 288
28Haemoblock----2件: 157, 280
29Haemocomplettan P----1件: 65
30Haemocomplettan(R) P----1件: 65
31Haemocomplettan(R) P 1g/2g----1件: 65
32HAEMOPHILUS INFLUENZAE----3件: 61, 62, 66
33HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 13, 14
34Haemophilus type b vaccine (conjugated)----1件: 14
35Haemostasis tests----1件: 113
36Halometasone1件: Halometasone1件: D07202 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 162
37Haloperidol1件: Haloperidol2件: D00136 ,
D01898 		1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8
38Haloperidol 2Mg Tab1件: Haloperidol2件: D00136 ,
D01898 		1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 8
39Haplo BM with T cell depletion----1件: 65
40Haplo HSCT----1件: 60
41Haplo/cord transplant----1件: 60
42Haploidentical Hematopoietic Cell Transplantation----2件: 60, 65
43Haploidentical HSCT using TBI free regimen, ''ATG'' with ''Post transplant cyclophosphamide''1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 60
44Harmonized supportive care----2件: 38, 39
45Harvoni1件: Sofosbuvir1件: D10366 --1件: 254
46HATG1件: Antilymphocyte immunoglobulin (horse)---1件: 60
47Havrix----1件: 46
48HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---7件: 2, 4, 6, 13, 46, 49, 113
49HBM9161 Dose A----1件: 63
50HBM9161 Dose B----1件: 63
51HBM9161 Injection----1件: 13
52HBM9161 Injection (340 mg)----1件: 11
53HBM9161 Injection (680mg and 340 mg)----1件: 11
54HBM9161 Injection (680mg)----1件: 11
55HBVAXPRO----2件: 46, 50
56HBVAXPRO 5 micrograms/0.5 ml1件: Hepatitis B Vaccine (Recombinant)---1件: 46
57HBVAXPRO 5 micrograms/0.5 ml Suspension for injection Hepatitis B vaccine (rDNA)1件: Hepatitis B Vaccine (Recombinant)---1件: 46
58HBVAXPRO® 40 micrograms1件: Hepatitis B Vaccine (Recombinant)---1件: 46
59HC-58----1件: 149
60HCQ----2件: 46, 49
61HCQ/CQ and CAB combined treatment----1件: 74
62HCT----1件: 67
63HD-TIV----1件: 46
64HE32861件: HE3286---2件: 46, 97
65HEC 68498----1件: 85
66HEC122505MsOH----1件: 6
67HEC585----1件: 85
68Helicobacter pylori eradication therapy----1件: 6
69Helium1件: Helium1件: D04420 --3件: 228, 299, 330
70Helium / oxygen mixed gas inhalation therapy2件: Helium,
Oxygen		2件: D00003 ,
D04420 		--1件: 330
71Helium-32件: Helium,
Helium He-3		1件: D04420 --2件: 228, 299
72Helminth ova----1件: 13
73Helopanflat Mono®----1件: 298
74Hematide1件: Peginesatide1件: D09946 1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283
75Hematide, peginesatide1件: Peginesatide1件: D09946 1件: EPOR 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283
76Hematopoetic stem cell infusion----1件: 13
77Hematopoetic Stem Cell Transplantation----5件: 19, 65, 120, 160, 326
78Hematopoietic bone marrow transplantation----1件: 36
79Hematopoietic Cell Transplantation----1件: 60
80Hematopoietic stem cell infusion----2件: 19, 20
81Hematopoietic Stem Cell Therapy----1件: 13
82Hematopoietic Stem Cell Transplant----2件: 65, 285
83Hematopoietic Stem Cell Transplantation----13件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285
84Hematopoietic stem cell transplantation (HSCT)----2件: 13, 60
85Hemay005----1件: 56
86Hemay007----1件: 97
87Hemay007 1200 mg QD group----1件: 46
88Hemay007 600 mg QD group----1件: 46
89Hemay007 800 mg QD group----1件: 46
90Heme arginate----1件: 254
91Hemin1件: Hemin1件: D10003 2件: ALAS1,
ALAS2 💬		4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254
92Hemin for injection1件: Hemin1件: D10003 2件: ALAS1,
ALAS2 💬		4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254
93Hemlibra1件: Emicizumab1件: D10821 2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288
94Hemlibra®1件: Emicizumab1件: D10821 2件: F10,
F9 💬		1件: Complement and coagulation cascades 💬1件: 288
95HEMOFIX----1件: 288
96Hemoglobin1件: Hemoglobin---1件: 298
97Heparesc----1件: 251
98Heparin1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬12件: 47, 60, 70, 79, 84, 107, 224, 226, 280, 299, 316, 317
99Heparin & Alkalinized Lidocaine Bladder Instillation2件: Heparin,
Lidocaine		4件: D00358 ,
D02086 ,
D07510 ,
D08127 		6件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SERPINC1 💬		4件: Adrenergic signaling in cardiomyocytes, Complement and coagulation cascades, Dopaminergic synapse, Taste transduction 💬1件: 226
100Heparin 25mg inhalation powder, hard capsule1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 299
101Heparin Sodium1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬2件: 280, 299
102Heparin-induced extracorporeal LDL precipitation1件: Heparin1件: D07510 1件: SERPINC1 💬1件: Complement and coagulation cascades 💬1件: 79
103Heparán N sulfatasa humana recombinante----1件: 19
104Heparán N sulfatasa humana recombinante (rhHNS)----1件: 19
105HepaStem----1件: 251
106HepaStem Infusion----1件: 251
107Hepatitis A Vaccine1件: Hepatitis A Vaccine---3件: 46, 96, 97
108Hepatitis A vaccine ( HAVRIX or EPAXAL)1件: Hepatitis A Vaccine---1件: 46
109Hepatitis A vaccine and tetanus vaccine1件: Hepatitis A Vaccine---1件: 46
110Hepatitis B Vaccine1件: Hepatitis B Vaccine (Recombinant)---1件: 46
111HEPATITIS B VACCINE (RDNA)1件: Hepatitis B Vaccine (Recombinant)---1件: 46
112HEPATITIS B VIRUS SURFACE ANTIGEN RECOMBINANT (S PROTEIN)----1件: 46
113Hepatocyte Transplant----1件: 240
114Heptaminol1件: Heptaminol1件: D07158 --1件: 6
115Heptaminol hydrochloride1件: Heptaminol1件: D07158 --1件: 6
116Heracillin----1件: 299
117Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.)1件: Reynoutria multiflora root---1件: 6
118Herbal medicine----1件: 70
119Herbal treatment (SA100)----1件: 97
120Hericium erinaceus mycelium----1件: 6
121Herpes Zoster Vaccine----3件: 46, 96, 271
122HESC-RPE----1件: 301
123Heshouwu1件: Reynoutria multiflora root---1件: 6
124Heterologous booster----1件: 13
125Heterologous Human Adult Liver-derived Progenitor Cells----1件: 251
126Heterologous Human Adult Liver-derived Progenitor Cells (HHALPC)----1件: 251
127Hetrombopag1件: Hetrombopag---2件: 60, 63
128Hetrombopag Olamine1件: Hetrombopag---2件: 60, 63
129Hetrombopag Olamine Tablet1件: Hetrombopag---1件: 60
130Hetrombopag Olamine+Standard Therapy1件: Hetrombopag---1件: 60
131Hextend1件: Hydroxyethyl Starch1件: D03335 --2件: 96, 97
132HF0220----1件: 6
133HF2----1件: 97
134HFNT during exercise----1件: 299
135Hgd40----1件: 97
136HGH----1件: 78
137HGH-hyFc, recombinant human growth hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
138HGH-ViaDerm™ System----1件: 78
139HGH-ViaDerm™ System (hGH or somatropin)1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
140HGP1206----1件: 86
141HGPIV diagnosis test----1件: 299
142HGS1006----1件: 49
143HGS1006, LymphoStat-B----1件: 53
144HGS1006, LymphoStat-B, monoclonal anti-BLyS, LSB, BENLYSTA1件: Belimumab1件: D03068 1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 49, 53
145HGS1025----1件: 97
146HGT-1110----1件: 19
147HGT-1111----1件: 19
148HGT-1410----1件: 19
149HGT-2310----1件: 19
150HHALPC----1件: 251
151HHLivC----1件: 251
152Hiberix1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 13, 61, 62, 66
153HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen---3件: 61, 62, 66
154HIDONAC*EV 1FL 5G 25ML----1件: 51
155Hidrocloruro de efedrina1件: Ephedrine1件: D00124 9件: ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬		14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 11
156Hidrocloruro de fingolimod1件: Fingolimod1件: D10001 1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14
157HIDROFEROL----1件: 113
158Hidroferol®----1件: 113
159HIDS DONOR----1件: 19
160High cheese intake.----1件: 238
161High Cut-off Hemodialysis----1件: 28
162High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device----1件: 226
163High Dietary Sodium----1件: 49
164High dose----1件: 97
165High dose AFFITOPE® PD03A + Adjuvant----1件: 6
166High dose ANAVEX2-73----1件: 6
167High Dose Aspirin (1300 mg/day)1件: Acetylsalicylic acid1件: D00109 2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13
168High dose BIBF 1120 twice daily----1件: 85
169High Dose Budesonide1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
170High dose budesonide suspension1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
171High dose budesonide tablet1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 98
172High dose Dexamethasone pulses1件: Dexamethasone9件: D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 63
173High dose lactulose1件: Lactulose1件: D00352 --1件: 291
174High dose levodopa1件: Levodopa1件: D00059 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
175High Dose Mesenchymal Stem Cells (MSCs)----1件: 49
176High Dose MT-1303----1件: 97
177High dose of BIIL 284 BS tablets----1件: 46
178High dose of budesonide1件: Budesonide1件: D00246 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 299
179High dose ORTD-1----1件: 46
180High dose TSO----1件: 96
181High dose vehicle control----1件: 46
182High Dose-VIS649----1件: 66
183High doses of Thiamine y Biotin2件: Biotin,
Thiamine		2件: D00029 ,
D08580 		--1件: 8
184High flow nasal oxygen cannula1件: Oxygen1件: D00003 --1件: 299
185High frequency ultrasonography----1件: 46
186High milk intake.----1件: 238
187High oleic sunflower oil1件: Sunflower oil1件: D09006 --1件: 240
188High Oligosaccharide Group----1件: 96
189High Phenolic Extra Virgin Olive Oil2件: Olea europaea leaf,
Olive oil		1件: D03311 --1件: 13
190High Protein and Low Fiber Diet----1件: 97
191High protein high fiber diet----2件: 93, 95
192High Protein. T-Diet plus Range----1件: 6
193High serine diet1件: Serine1件: D00016 --1件: 96
194High water intake1件: Water1件: D00001 --1件: 67
195High-caloric fatty diet----1件: 2
196High-carbohdyrate breakfast----1件: 265
197High-dose Cyclophosphamide1件: Cyclophosphamide2件: D00287 ,
D07760 		--1件: 96
198High-dose intravenous immunoglobulin (IVIG)----1件: 18
199High-dose intravenous immunoglobulin (Venoglobulin-IH)----1件: 51
200High-dose REGN4461----1件: 265
201High-dose vitamin D (2000 IU per day)1件: Vitamin D---1件: 274
202High-Dose Vitamin D31件: Cholecalciferol1件: D00188 1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 299
203High-Frequency-Only Stimulation----1件: 6
204High-resolution peripheral quantitative computed tomography (HR-pQCT)----1件: 46
205High/Low Sodium Diet----1件: 13
206Hiomega-3 supplement of Naturalis® company -----1件: 49
207Histamine1件: Histamine1件: D08040 4件: HRH1,
HRH2,
HRH3,
HRH4 💬		4件: Calcium signaling pathway, Gastric acid secretion, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13
208Histidine1件: Histidine1件: D00032 --3件: 13, 169, 170
209Histone Deacetylase Inhibitor----1件: 127
210History and physical----1件: 231
211History and physical exam.----2件: 231, 299
212Histrelin1件: Histrelin1件: D02369 1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76
213Histrelin Subcutaneous Implant1件: Histrelin1件: D02369 1件: GNRHR 💬2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76
214Hizentra1件: Human immunoglobulin G---4件: 14, 50, 51, 65
215HIZENTRA ®----1件: 11
216Hizentra®1件: Human immunoglobulin G---2件: 14, 65
217HK-001----1件: 2
218HL237----1件: 46
219HL237 tablet----1件: 46
220HLA-identical allogeneic mesoangioblasts----1件: 113
221HLB-001----1件: 246
222HLL2----1件: 49
223HLL2 (Epratuzumab)1件: Epratuzumab1件: D04036 1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49
224HLL2 (trivial name or chemical description)----1件: 49
225HLL2,IMMU-103----1件: 49
226HLX01----1件: 46
227HM10560A----1件: 78
228HM201----2件: 96, 97
229HM71224 food effect----1件: 46
230HM71224 Multiple ascending dose----1件: 46
231HM71224 single ascending dose----1件: 46
232HMABs----1件: 113
233HMED-IdeS1件: Imlifidase1件: D11470 --2件: 64, 221
234HMG-Coenzyme inhibitor (statin)----1件: 218
235HMI-103----1件: 240
236HMPL-004----2件: 96, 97
237HMPL-004 1800 mg/day----1件: 97
238HMPL-004 2400 mg/day----1件: 97
239HMPL-004 high dose----1件: 97
240HMPL-004 low dose----1件: 97
241HMPL-523----2件: 46, 63
242HMPL004-6599----2件: 96, 97
243HMR 1726D----1件: 13
244HMR1726----1件: 13
245HMR1726D----1件: 13
246HMSCs----1件: 299
247Hologene 5----1件: 36
248Hologene 5 DS----1件: 36
249HOLOGENE17----1件: 36
250HOLOGENE7----1件: 36
251HOMAR-IR diagnosis test----1件: 299
252Home based balance training1件: Isoxaflutole---2件: 6, 13
253Home Oral Glucose Tolerance Test kit1件: Dextrose, unspecified form---1件: 299
254Homeostasis Model Assessment of insulin resistance (HOMA)----1件: 17
255Homocysteine1件: Homocysteine---1件: 229
256Homologous booster----1件: 13
257Honey1件: Honey1件: D06776 --3件: 57, 98, 299
258Hookworm larvae----1件: 13
259HORA-PDE6B (AAV2/5.hPDE6B)----1件: 90
260Hormonal balance measurements1件: Isoxaflutole---1件: 81
261Hormonal profile----1件: 113
262Hormone (prednisone)1件: Prednisone1件: D00473 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 66
263Horse -Anti-thymocyte----1件: 65
264Horse anti-thymocyte globulin1件: Antilymphocyte immunoglobulin (horse)---1件: 60
265Horse anti-thymocyte globulin (ATG)1件: Antilymphocyte immunoglobulin (horse)---1件: 60
266Horse anti-thymocyte globulin (hATG)1件: Antilymphocyte immunoglobulin (horse)---1件: 60
267Horse chestnut1件: Horse chestnut1件: D12028 --1件: 210
268Horse-Anti-thymocyte-Globulin----1件: 60
269Hourly dosing of the nychtemeral secretion of melatonin1件: Melatonin1件: D08170 2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 202
270HOV-12020 (Palm tocotrienols complex)----1件: 124
271HP 129Xe----1件: 299
272Hp 129Xenon----1件: 228
273HP 3He----1件: 299
274HP-3000 (ropinirole hydrochloride patch)1件: Ropinirole2件: D00784 ,
D08489 		3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
275HP-3000 placebo----1件: 6
276HP-3000(ropinirole hydrochloride patch)1件: Ropinirole2件: D00784 ,
D08489 		3件: DRD2,
DRD3,
DRD4 💬		8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6
277HP184----1件: 13
278HP802-247----1件: 36
279HPC cell infusion----1件: 45
280HPC, A Infusion----1件: 60
281HPN-100----1件: 251
282HPV prophylactic vaccine Gardasil1件: Human papillomavirus type 6 L1 capsid protein antigen---1件: 49
283HR19042 capsule----1件: 66
284HR19042 Capsules----1件: 66
285HRA052015----1件: 75
286HRA052015 (mifepristone)1件: Mifepristone1件: D00585 2件: NR3C1,
PGR 💬		6件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 75
287HrIL-2 active----3件: 46, 49, 53
288HRPC----1件: 90
289HRPC DP----1件: 90
290HST5040----2件: 245, 246
291HT-100----1件: 113
292HTD1801----1件: 94
293HTD1801 (BUDCA)----1件: 93
294HTEA----1件: 57
295HTK cardioplegia----1件: 215
296HTLP----1件: 65
297Hu Leptin (A-100)1件: Leptin---1件: 265
298Hu MiK-Beta-1----1件: 26
299Huaiqihuang Granule----1件: 63
300Huaiqinhuang----1件: 224
301Huang qi gui zhi wu wu granule----1件: 46
302HUC-MSC + DMARDs----1件: 46
303HUC-MSC infusion (BC-U001)----1件: 46
304HUC-MSC suspension----1件: 46
305HuCNS-SC----1件: 19
306HuCNS-SC cells----1件: 139
307HuCNS-SC transplant in the lead-in phase----1件: 139
308HuL001----1件: 13
309Hulio1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
310HuM291----2件: 96, 97
311Humalog Mix50 100 U/ml sospensione iniettabile----1件: 78
312Human acylated ghrelin1件: Lenomorelin---1件: 78
313Human albumin1件: Albumin human2件: D02792 ,
D05424 		--2件: 2, 96
314HUMAN ALBUMIN AS MACROAGGREGATES1件: Albumin human2件: D02792 ,
D05424 		--1件: 96
315HUMAN ALBUMIN SOLUTION1件: Albumin human2件: D02792 ,
D05424 		--1件: 2
316Human allogeneic adipose tissue-derived mesenchymal stem cells expanded----1件: 36
317Human Allogeneic WJ-MSCs1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36
318Human Amniotic Epithelial Stem Cells----1件: 6
319Human anti TNF-alpha monoclonal----1件: 46
320Human anti TNF-alpha monoclonal antibody----2件: 46, 84
321Human anti-IL 12/23 monoclonal antibody----1件: 84
322Human Anti-IL-12 Antibody----1件: 96
323Human anti-IL-12 IgG1 Mab----1件: 13
324Human anti-IL-12 Mab----1件: 13
325Human anti-IL6 monoclonal antibody----1件: 46
326Human anti-IP10 monoclonal antibody----2件: 96, 97
327Human anti-LINGO-1 monoclonal antibody----1件: 13
328HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY----1件: 3
329Human Anti-TNF IgG1 Monoclonal Antibody----3件: 46, 97, 271
330Human anti-TNF-alpha monoclonal antibody----3件: 46, 97, 107
331Human anti-TNFa monoclonal antibody----1件: 271
332Human Anti-TNFalfa----3件: 46, 97, 271
333Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody----1件: 51
334Human autologous mesenchymal stem cells----2件: 2, 13
335HUMAN COAGULATION FACTOR VIII1件: Antihemophilic factor human---1件: 288
336Human coagulation Factor VIII / von Willebrand Factor3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288
337Human coagulation factor VIII associated with Von Willebrand factor (VWF)3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288
338HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX3件: Antihemophilic factor human,
Beroctocog alfa,
Von Willebrand factor human		---1件: 288
339Human Coagulation FACTOR X1件: Coagulation factor X human---1件: 288
340Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh----1件: 36
341Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE)----1件: 90
342Human factor X1件: Coagulation factor X human---1件: 288
343Human fetal-derived Neural Stem Cells (hNSCs)----1件: 13
344HUMAN FIBRINOGEN1件: Fibrinogen human---1件: 65
345Human Fibrinogen Concentrate1件: Fibrinogen human---1件: 65
346Human fibroblast-derived dermal substitute, Dermagraft----1件: 36
347Human Glucocerebrosidase (prGCD)1件: Taliglucerase alfa1件: D09675 1件: GBA 💬4件: Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬1件: 19
348Human Growth Hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬4件: 78, 187, 193, 265
349Human Growth Hormone (1-134)1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
350Human Heterologous Liver Cells----1件: 251
351Human heterologous liver cells (for infusion)----1件: 251
352HUMAN IGG4 ISOTYPE MONOCLONAL (IL2-RG) ANTIBODY----1件: 60
353Human Immunglobulin G (IgG)----1件: 65
354Human Immunoglobulin----2件: 63, 65
355HUMAN IMMUNOGLOBULIN G1件: Human immunoglobulin G---4件: 14, 50, 63, 65
356Human insulin1件: Insulin human2件: D00085 ,
D03230 		1件: INSR 💬22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬2件: 96, 156
357Human interferon beta1件: Human interferon beta---2件: 13, 26
358Human interferon beta 1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: D04554 2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13
359Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		2件: D04318 ,
D04554 		22件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G,
IFNAR1,
IFNAR2 💬		44件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13
360Human interleukin-21件: Human interleukin-2---1件: 35
361HUMAN LEUCOCYTE INTERFERON-ALPHA----1件: 13
362Human Monoclonal Antibody (CNTO 1275) to Interleukin 12p-40----1件: 96
363Human monoclonal antibody (CNTO 1275) to interleukin-12p40----1件: 13
364Human monoclonal antibody directed against CD20 on B-cells----1件: 46
365Human monoclonal antibody directed against complement 5 protein----1件: 62
366Human neural stem cell----1件: 6
367Human Neural Stem Cells----2件: 2, 13
368Human normal 10% immunoglobulin for intravenous administration1件: Human immunoglobulin G---1件: 14
369Human normal 10% immunoglobulin for intravenous administrationn1件: Human immunoglobulin G---1件: 14
370Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65
371HUMAN NORMAL IMMUNOGLOBULIN (IV)1件: Human immunoglobulin G---4件: 11, 14, 63, 65
372Human normal immunoglobulin (IVIg)1件: Human immunoglobulin G---3件: 14, 50, 65
373Human normal immunoglobulin (SCIg)1件: Human immunoglobulin G---1件: 14
374Human Normal Immunoglobulin (Subcutaneous - Intramuscular Immunoglobulin)1件: Human immunoglobulin G---1件: 65
375Human normal immunoglobulin (subcutaneous)1件: Human immunoglobulin G---1件: 65
376HUMAN NORMAL IMMUNOGLOBULIN FOR1件: Human immunoglobulin G---1件: 65
377Human normal immunoglobulin for intravenous (IV) administration1件: Human immunoglobulin G---1件: 51
378Human normal immunoglobulin for intravenous administration1件: Human immunoglobulin G---3件: 14, 51, 65
379HUMAN NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE1件: Human immunoglobulin G---2件: 63, 65
380Human normal immunoglobulin for intravenous use (IVIG)1件: Human immunoglobulin G---1件: 65
381HUMAN NORMAL IMMUNOGLOBULIN FOR INTRVENOUS USE1件: Human immunoglobulin G---1件: 63
382Human normal immunoglobulin for subcutaneous administration1件: Human immunoglobulin G---2件: 51, 65
383Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)1件: Human immunoglobulin G---1件: 65
384Human normal immunoglobulin G (IgG > 98% purity)1件: Human immunoglobulin G---3件: 14, 63, 65
385Human normal immunoglobulin G (IgG)1件: Human immunoglobulin G---1件: 11
386Human normal immunoglogulin (IVIg)1件: Human immunoglobulin G---1件: 50
387Human papillomavirus vaccination (Gardasil)1件: Human papillomavirus type 6 L1 capsid protein antigen---1件: 49
388Human Placenta-Derived Cells PDA001 Intravenous Infusion----1件: 96
389Human Placental Derived Stem Cell----4件: 19, 20, 60, 284
390HUMAN PLASMA FOR FRACTIONATION----1件: 96
391Human primary Retinal Pigment Epithelial (HuRPE) cells----1件: 90
392Human recombinant growth hormone1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 13, 299
393Human Recombinant IgG1, lambda----1件: 46
394Human recombinant leptin (metreleptin)2件: Leptin,
Metreleptin		1件: D05014 1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265
395Human recombinant parathyroid Hormone1件: Parathyroid hormone1件: D05364 2件: PTH1R,
PTH2R 💬		3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235
396Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein1件: Alkaline Phosphatase---1件: 172
397Human retinal progenitor cells----1件: 90
398Human Retinal Progenitor Cells Drug Product----1件: 90
399Human Secretin1件: Secretin human---1件: 298
400Human serum albumin1件: Albumin human2件: D02792 ,
D05424 		--1件: 78
401HUMAN SERUM ALBUMIN (HSA) FUSED TO RECOMBINANT HUMAN GROWTH HORMONE (HGH)2件: Albumin human,
Somatotropin		3件: D02691 ,
D02792 ,
D05424 		1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
402Human Serum Albumin (HSA) fused to somatropin2件: Albumin human,
Somatotropin		3件: D02691 ,
D02792 ,
D05424 		1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
403Human soluble recombinant Fc-gamma receptor IIB----1件: 66
404Human Stem Cells----1件: 6
405Human T Lymphoid Progenitor (HTLP) injection----1件: 65
406Human Transthyretin Antisense Oligonucleotide----1件: 28
407Human Umbilical Cord Blood-derived Mesenchymal Stem Cells----1件: 36
408Human umbilical cord derived MSC transplantation for SLE----1件: 49
409Human Umbilical Cord Mesenchymal Stem Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---3件: 13, 96, 113
410Human umbilical cord mesenchymal stem cells (UC-MSCs)1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 96
411Human umbilical cord-derived MSCs----1件: 271
412HUMAN VON WILLEBRAND FACTOR1件: Von Willebrand factor human---1件: 288
413Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII)2件: Beroctocog alfa,
Von Willebrand factor human		---1件: 288
414Human VWF/FVIII concentrate----1件: 288
415Humanised anti-CD 20 antibody----1件: 46
416Humanised anti-CD4 IgG1 monoclonal----1件: 46
417Humanised IgG1 monoclonal antibody against blood dendritic cell antigen 2----1件: 49
418Humanised IgG1 monoclonal antibody against human eotaxin-2----1件: 94
419Humanised IgG1K monoclonal antibody against interferon beta1件: Human interferon beta---1件: 50
420Humanized anti-alpha v beta 6 mAb----1件: 85
421Humanized IgG1 kappa antiamyloid----1件: 28
422Humanized IgG1, kappa anti-serum amyloid A and anti-AL amyloid antibody----1件: 28
423Humanized immunoglobulin gamma 1 (IgG1) kappa monoclonal antibody----1件: 46
424Humanized recombinant IgG4 monoclonal antibody against CD-127----1件: 97
425Humanized TNFa monoclonal antibody----1件: 46
426Humate-P1件: Von Willebrand factor human---1件: 288
427Humatrope----2件: 78, 274
428Humatrope 6 mg/12 mg/24 mg injektiokuiva-aine ja liuotin, liuosta varten1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 193
429Humatrope® 6 mg, powder and solvent for solution for injection1件: Somatotropin1件: D02691 1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 78
430HuMax-CD201件: Ofatumumab1件: D09314 1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 46
431HUMAX-CD38----2件: 28, 63
432HuMax-CD38, 3003-005----1件: 28
433HuMax-CD4----1件: 46
434HUMIRA----9件: 46, 56, 84, 96, 97, 107, 160, 269, 271
435Humira (adalimumab original)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
436HUMIRA (ADALIMUMAB)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96
437Humira (adalimumab) 40 mg in 0.4 ml s.c. injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
438Humira (adalimumab) 40 mg s.c. injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
439Humira (adalimumab) 40mg in 0.4 ml s.c. injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
440Humira (adalimumab) 40mg in 0.4ml s.c.injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
441HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA 0.8 ML + 1 TAMPONE IMBEVUTO DI ALCOL IN UN BLISTER1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 56, 97
442HUMIRA - 40 MG SOLUZIONE INIETTABILE USO SOTTOCUTANEO 2 SIRINGHE PRERIEMPITE 0.8 ML + 2 TAMPONI IMBEVUTI DI ALCOL IN 1 BLISTER1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
443HUMIRA - 40MG/0.8ML SOLUZ. INIETTABILE- USO SOTTOCUTANEO-FLACONCINO(VETRO) 0.8ML 2 ASTUCCI:1 FLACONCINO+1SIRINGA+1AGO+1ADATT.STERILE-2TAMPONI IMBEVUTI ALCOOL----2件: 46, 96
444Humira 20 mg solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
445Humira 20 mg solution for injection in pre-filled syringe (20 mg/0.2mL)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
446Humira 40 mg injekcní roztok v predplnené injekcní stríkacce1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
447Humira 40 mg injeksjonsvæske, oppløsning, i ferdigfylt sprøyte----1件: 46
448HUMIRA 40 mg solución inyectable en jeringa precargada1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96
449Humira 40 mg solution for injection in pre-filled pen1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
450Humira 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 96, 97
451Humira 40 mg solution for injection in pre-filled syringe (40 mg/0.4 mL)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
452Humira 40 mg solution for injection in pre-filled syringes----1件: 97
453Humira 40 mg/0.8 ml solution for injection1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 96, 97, 271
454Humira 40 mg/0.8 ml solution for injection for paediatric use1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
455Humira 40mg Injektionslösung----1件: 46
456HUMIRA 40Mg Solution for Injection----2件: 96, 97
457Humira 40mg solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
458Humira 40mg solution for injection in pre-filled syringe (adalimumab)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
459Humira 40mg/0.4ml pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
460Humira 40mg/0.8 ml solution for injection for paediatric use1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
461Humira 40mg/0.8ml solution for injection for paediatric use1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 96
462Humira 40mg/0.8ml solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
463Humira 80 mg solution for injection in pre-filled syringe (80 mg/0.8 mL)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97
464Humira pre-filled PEN----1件: 96
465Humira SC----1件: 46
466HUMIRA ®1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 96, 97
467Humira ® (Adalimumab) 40mg/0.8mL Pre-filled Syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
468HUMIRA*SC 2SIR+F 40MG 0,8ML+2T1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96
469Humira, 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
470Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
471Humira®----5件: 46, 96, 97, 107, 271
472Humira® (adalimumab)1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
473Humira® 40 mg Injektionslösung in Fertigspritze1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
474Humira® 40 mg solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
475Humira® 40 mg/ 0.8 ml solution for injection in pre-filled syringe1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
476Hunterase1件: Idursulfase beta1件: D11025 1件: IDS 💬3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬1件: 19
477Huolingshengji Granules----1件: 2
478Hyaluronan1件: Hyaluronic acid1件: D08043 --1件: 299
479Hyaluronate1件: Hyaluronic acid1件: D08043 --2件: 53, 97
480Hyaluronic acid1件: Hyaluronic acid1件: D08043 --5件: 46, 53, 70, 226, 231
481Hyaluronic Acid and Chondroitin Sulfate3件: Chondroitin sulfate,
Hyaluronic acid,
Sulfate ion		1件: D08043 --1件: 226
482Hyaluronic Acid Inhalation Solution1件: Hyaluronic acid1件: D08043 --1件: 231
483Hyaluronic acid/chondroitin sulfate3件: Chondroitin sulfate,
Hyaluronic acid,
Sulfate ion		1件: D08043 --1件: 226
484Hyaluronidase1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--5件: 14, 28, 51, 65, 331
485Hyaluronidase injected intradermally1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--1件: 51
486Hyaluronoglucosaminidase1件: Hyaluronidase3件: D04455 ,
D04456 ,
D06604 		--1件: 65
487Hydralazine1件: Hydralazine2件: D01302 ,
D08044 		1件: AOC3 💬5件: Glycine, serine and threonine metabolism, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, beta-Alanine metabolism 💬1件: 67
488Hydrochloorthiazide----1件: 225
489HYDROCHLOROTHIAZIDE1件: Hydrochlorothiazide1件: D00340 1件: SLC12A3 💬-4件: 13, 67, 225, 235
490Hydrochlorothiazide/amiloride2件: Amiloride,
Hydrochlorothiazide		3件: D00340 ,
D00649 ,
D07447 		4件: SCNN1A,
SCNN1B,
SCNN1G,
SLC12A3 💬		3件: , Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 225
491Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----1件: 83
492Hydrocortisone1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
493Hydrocortisone (Solucortef)1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
494Hydrocortisone 100mg/ml1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83
495Hydrocortisone 10mg1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 46
496Hydrocortisone 10mg Tablet1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
497Hydrocortisone 10mg Tablets1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
498Hydrocortisone 20mg Tablets1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
499HYDROCORTISONE ACETATE3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: D00088 ,
D00165 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 97
500Hydrocortisone cream1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6
501Hydrocortisone cream 1%1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6
502Hydrocortisone cream 10mg/g FNA Fagron1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 6
503HYDROCORTISONE HYDROGEN SUCCINATE3件: Hydrocortisone,
Hydrocortisone succinate,
Hydrogen		2件: D00088 ,
D01442 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83
504HYDROCORTISONE MICRONIZED1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
505Hydrocortisone Modified Release Capsules1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
506HYDROCORTISONE ROUSSEL1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83
507Hydrocortisone sodium acetate3件: Acetate,
Hydrocortisone,
Sodium acetate		2件: D00088 ,
D01779 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
508HYDROCORTISONE SODIUM PHOSPHATE2件: Hydrocortisone,
Phosphate ion		1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 53, 81, 83
509HYDROCORTISONE SODIUM SUCCINATE1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 81, 83, 97
510Hydrocortisone tablet 2.5 mg1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
511Hydrocortisone TAKEDA, tabletter1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 78
512Hydrocortisone withdrawal1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
513HYDROCORTISONE- hydrocortisone tablet1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 81
514Hydrocortisonum1件: Hydrocortisone1件: D00088 1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 83
515Hydrocortone----1件: 78
516Hydrogen1件: Hydrogen---7件: 5, 6, 13, 17, 83, 97, 226
517Hydrogen peroxide2件: Hydrogen,
Hydrogen peroxide		1件: D00008 --1件: 13
518Hydrokortison----1件: 41
519Hydrokortison APL kapsel 2,5 mg----1件: 83
520Hydrokortison Glostrup 5 mg----1件: 78
521Hydrokortison orion----1件: 41
522Hydrolyzed guar gum1件: Guar gum1件: D04403 --1件: 6
523Hydromorphone1件: Hydromorphone2件: D00839 ,
D08047 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 70
524Hydroxide1件: Hydroxide ion---5件: 11, 46, 96, 97, 284
525Hydroxocobalamin1件: Hydroxocobalamin3件: D01027 ,
D02707 ,
D04929 		--1件: 97
526Hydroxocobalamin with Butyrate2件: Butyric Acid,
Hydroxocobalamin		4件: D01027 ,
D02707 ,
D04929 ,
D05866 		--1件: 97
527Hydroxychloroquine1件: Hydroxychloroquine1件: D08050 --27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299
528Hydroxychloroquine (Z0188)1件: Hydroxychloroquine1件: D08050 --1件: 49
529Hydroxychloroquine + low-dose prednisone2件: Hydroxychloroquine,
Prednisone		2件: D00473 ,
D08050 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
530Hydroxychloroquine + Prednisone2件: Hydroxychloroquine,
Prednisone		2件: D00473 ,
D08050 		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 84
531Hydroxychloroquine 400mg/d1件: Hydroxychloroquine1件: D08050 --1件: 53
532Hydroxychloroquine and Indapamide2件: Hydroxychloroquine,
Indapamide		3件: D00345 ,
D06401 ,
D08050 		1件: SLC12A3 💬-1件: 13
533Hydroxychloroquine higher dose1件: Hydroxychloroquine1件: D08050 --1件: 90
534Hydroxychloroquine lower dose1件: Hydroxychloroquine1件: D08050 --1件: 90
535Hydroxychloroquine or Chloroquine2件: Chloroquine,
Hydroxychloroquine		4件: D02125 ,
D02366 ,
D03469 ,
D08050 		--1件: 49
536Hydroxychloroquine reduced1件: Hydroxychloroquine1件: D08050 --1件: 49
537HYDROXYCHLOROQUINE SULFATE2件: Hydroxychloroquine,
Sulfate ion		1件: D08050 --3件: 46, 53, 66
538Hydroxychloroquine Sulfate 100 milligram (mg) Tab2件: Hydroxychloroquine,
Sulfate ion		1件: D08050 --1件: 218
539HYDROXYCHLOROQUINE SULPHATE1件: Hydroxychloroquine1件: D08050 --1件: 96
540Hydroxycholoquine----1件: 46
541Hydroxycloroquina----1件: 46
542Hydroxypropyl-beta-cyclodextrin1件: Betadex1件: D02401 --1件: 19
543Hydroxypropyl-ß-cyclodextrin----1件: 19
544HYDROXYPROPYLBETADEX----1件: 19
545Hydroxytyrosol1件: Hydroxytyrosol---1件: 13
546Hydroxyurea1件: Hydroxyurea1件: D00341 1件: RRM2 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬8件: 3, 13, 19, 20, 65, 85, 86, 284
547Hylase----1件: 46
548HYNR-CS inj----1件: 2
549HYNRCS-Allo inj----1件: 2
550Hyperbaric Oxygen1件: Oxygen1件: D00003 --2件: 46, 97
551Hyperbaric oxygen therapy1件: Oxygen1件: D00003 --1件: 90
552Hypercortisolism----1件: 75
553Hyperglycemic clamp----1件: 299
554Hyperglycemic Clamp with concurrent GIP infusion----1件: 299
555Hyperglycemic clamp with concurrent GLP-1 infusion----1件: 299
556Hyperimmune caprine serum----1件: 51
557Hyperimmune caprine serum against HIV lysate----1件: 13
558Hyperinsulinemic euglycemic clamp----2件: 316, 317
559HYPERIUM1件: Rilmenidine1件: D08482 3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 8
560Hyperoxia----2件: 51, 85
561Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment1件: Xenon2件: D01901 ,
D06339 		--1件: 85
562Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment1件: Xenon2件: D01901 ,
D06339 		--1件: 85
563Hyperpolarized 129-Xenon gas1件: Xenon2件: D01901 ,
D06339 		--1件: 85
564Hyperpolarized 129Xe----1件: 86
565Hyperpolarized 13C-Pyruvate----1件: 58
566Hyperpolarized [1-13C]pyruvate----2件: 2, 67
567Hyperpolarized Helium-32件: Helium,
Helium He-3		1件: D04420 --1件: 299
568Hyperpolarized Helium-3 MRI2件: Helium,
Helium He-3		1件: D04420 --1件: 228
569Hyperpolarized Helium-3 MRI of the chest2件: Helium,
Helium He-3		1件: D04420 --1件: 299
570Hyperpolarized Xe129----2件: 85, 299
571Hyperpolarized Xenon1件: Xenon2件: D01901 ,
D06339 		--1件: 299
572Hyperpolarized Xenon 1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
573Hyperpolarized Xenon gas1件: Xenon2件: D01901 ,
D06339 		--1件: 299
574Hyperpolarized xenon-1291件: Xenon2件: D01901 ,
D06339 		--1件: 299
575Hypersaline----1件: 294
576Hypertonic bicarbonate----1件: 299
577HYPERTONIC SALINE----1件: 299
578Hypertonic saline (7 %) and isotonic saline (0.9%)----1件: 299
579Hypertonic saline (7%)----1件: 299
580Hypertonic saline 6% -----1件: 299
581Hypertonic Saline 7%1件: Sodium chloride1件: D02056 --1件: 299
582Hypertonic saline solution1件: Sodium chloride1件: D02056 --1件: 299
583Hypoestoxide----1件: 6
584HypotonicTreprostinil Solution----1件: 86
585Hypoxic Gas Mixture----1件: 6
586Hypro----1件: 75
587HyQvia1件: Hyaluronidase (human recombinant)---2件: 14, 65
588HyQvia 100 mg/ml solution for infusion for subcutaneous use1件: Human immunoglobulin G---1件: 65
589Hyrimoz1件: Adalimumab1件: D02597 1件: TNF 💬67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271
590HZN-825----2件: 51, 85
591HZN-825 BID----1件: 51
592HZN-825 QD----1件: 51
593HZT-5011件: HZT-501---1件: 46